Top

Published in:

Open Access 01-09-2014 | Original Article

Hypermethylation of the enolase gene (ENO2) in autism

Authors: Yu Wang, Yudan Fang, Fengling Zhang, Miao Xu, Jingzhi Zhang, Jingbin Yan, Weina Ju, W. Ted Brown, Nanbert Zhong

Published in: European Journal of Pediatrics | Issue 9/2014

Abstract

It has been hypothesized that dysregulation of brain-expressed genes is the major predisposing underlying mechanism for autism. This dysregulation may be mediated by differential methylation of CpG sites within gene promoters, which could be candidate biomarkers and used for early clinical screening of autism. A total of 131 pairs of age- and sex-matched autistic and control subjects were recruited in this study. Peripheral blood cells were analyzed. The first five pairs were randomly applied to array-based genome-wide methylation studies. A neuron-specific gene, ENO2, was found to be hypermethylated in the autistic samples. This difference was validated by bisulfite sequencing PCR (BSP). The differential expression of ENO2 gene was further analyzed with RT-qPCR and ELISA. The hypermethylation of ENO2 within the promoter region was confirmed by BSP to be present in 14.5 % (19/131) of the total of the autistic samples. The mean ENO2 RNA level in these 19 autistic samples was reduced by about 70 % relative to that in controls. The average level of ENO2 protein expression in the 19 autistic samples (15.18 ± 3.51 μg/l) was about half of that in the controls (33.86 ± 8.16 μg/l). Conclusion: These findings suggest that reduced ENO2 expression may be a biomarker for a subset of autistic children.

Available only for authorised users

Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341–355PubMedCentralPubMedCrossRef

Chowdhury S, Erickson SW, MacLeod SL, Cleves MA, Hu P, Karim MA, Hobbs CA (2011) Maternal genome-wide DNA methylation patterns and congenital heart defects. PLoS One 6:e16506PubMedCentralPubMedCrossRef

Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P, Rocke DM, Sharp FR (2007) A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 12:292–306PubMed

Ganz ML (2006) The costs of autism. In: Moldin SO, Rubenstein JLR (eds) Autism: from basic neuroscience to treatment. CRC, Boca Raton, pp 76–98

Geschwind DH (2009) Advances in autism. Annu Rev Med 60:367–380PubMedCentralPubMedCrossRef

Gomes MV, Toffoli LV, Arruda DW, Soldera LM, Pelosi GG, Neves-Souza RD, Freitas ER, Castro DT, Marquez AS (2012) Age-related changes in the global DNA methylation profile of leukocytes are linked to nutrition but are not associated with the MTHFR C677T genotype or to functional capacities. PLoS One 7:e52570. doi:10.1371/journal.pone.0052570 PubMedCentralPubMedCrossRef

Henikoff S, Matzke MA (1997) Exploring and explaining epigenetic effects. Trends Genet 13:293–295PubMedCrossRef

Junaid MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A 131:11–17PubMedCentralPubMedCrossRef

Kuehn BM (2007) CDC: autism spectrum disorders common. JAMA 297:940PubMedCrossRef

10.

Liao DL, Cheng MC, Lai CH, Tsai HJ, Chen CH (2011) Comparative gene expression profiling analysis of lymphoblastoid cells reveals neuron-specific enolase gene (ENO2) as a susceptibility gene of heroin dependence. Addict Biol. doi:10.1111/j.1369-600

11.

Martins-de-Souza D, Gattaz WF, Schmitt A, Novello JC, Marangoni S, Turck CW, Dias-Neto E (2009) Proteome analysis of schizophrenia patients Wernicke’s area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17PubMedCentralPubMedCrossRef

12.

Martins-de-Souza D, Schmitt A, Roder R, Lebar M, Schneider-Axmann T, Falkai P, Turck CW (2010) Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J Psychiatr Res 44:989–991PubMedCrossRef

13.

Mill J, Tang T, Kaminsky Z et al (2008) Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82:696–711PubMedCentralPubMedCrossRef

14.

Momeni N, Bergquist J, Brudin L, Behnia F, Sivberg B, Joghataei MT, Persson BL (2012) A novel blood-based biomarker for detection of autism spectrum disorders. Transl Psychiatry 13:e91. doi:10.1038/tp.2012.19 CrossRef

15.

Nagarajan RP, Hogart AR, Gwye Y, Martin MR, Lasalle JM (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 1:172–182CrossRef

16.

Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, Hansen RL, Van de Water J, Pessah IN, Jiang R, Robinson WP, LaSalle JM (2008) MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res 1:169–178PubMedCentralPubMedCrossRef

17.

Nguyen A, Rauch TA, Pfeifer GP, Hu VW (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 24:3036–3051PubMedCentralPubMedCrossRef

18.

Ptak C, Petronis A (2010) Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci 12:25–35PubMedCentralPubMed

19.

Rajendram R, Ferreira JC, Grafodatskaya D, Choufani S, Chiang T, Pu S, Butcher DT, Wodak SJ, Weksberg R (2011) Assessment of methylation level prediction accuracy in methyl-DNA immunoprecipitation and sodium bisulfite based microarray platforms. Epigenetics 6:410–415PubMedCrossRef

20.

Sandler SJ, Figaji AA, Adelson PD (2010) Clinical applications of biomarkers in pediatric traumatic brain injury. Childs Nerv Syst 26:205–213PubMedCrossRef

21.

Schanen NC (2006) Epigenetics of autism spectrum disorders. Hum Mol Genet 15:138–150CrossRef

22.

Schwarz E, Guest PC, Rahmoune H et al (2011) Sex-specific serum biomarker patterns in adults with Asperger’s syndrome. Mol Psychiatry 16:1213–1220PubMedCrossRef

23.

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33PubMed

24.

Shen C, Zhao XL, Ju W, Zou XB, Huo LR, Yan W, Zou JH, Yan GD, Jenkins EC, Brown WT, Zhong N (2010) A proteomic investigation of B lymphocytes in an autistic family: a pilot study of exposure to natural rubber latex (NRL) may lead to autism. J Mol Neurosci 43:443–452PubMedCrossRef

25.

Spivak B, Schechtman M, Schonherz-Pine Y, Blumensohn R, Mostovoy S, Amital D, Deckmann M, Weizman A, Shinitzky M (2009) Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients-part II: adult subjects. Neuropsychobiology 60:49–54PubMedCrossRef

26.

Sung HJ, Cho JY (2008) Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41:615–625PubMedCrossRef

27.

Suzuki MM, Bird A (2008) DNA methylation landscapes: provoca-tive insights from epigenomics. Nat Rev Genet 9:465–476

28.

Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T (2009) The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 19:1974–1982PubMedCentralPubMedCrossRef

29.

Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, Wainstein J, Friedlander Y, Levy-Lahad E, Glaser B (2012) Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 21:371–383PubMedCentralPubMedCrossRef

30.

Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380–384PubMedCentralPubMedCrossRef

31.

Wang Y, Zhong N (2012) Clinical and genetic heterogeneity of autism. In: Cooper, Chen (eds) Mutations in human genetic disease, 2nd edn. InTech, Croatia, pp 217–232

Title: Hypermethylation of the enolase gene (ENO2) in autism
Authors: Yu Wang
Yudan Fang
Fengling Zhang
Miao Xu
Jingzhi Zhang
Jingbin Yan
Weina Ju
W. Ted Brown
Nanbert Zhong
Publication date: 01-09-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Pediatrics / Issue 9/2014
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-014-2311-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Hypermethylation of the enolase gene (ENO2) in autism

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2014

Don’t miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation

Predictors of indoor smoking at young children’s homes—a cross-sectional study

Safety and tolerance of a new extensively hydrolyzed rice protein-based formula in the management of infants with cow’s milk protein allergy

Microcephalic osteodysplastic primordial dwarfism type II (MOPD II) with multiple vascular complications misdiagnosed as Dubowitz syndrome

Quality of life and behavioral functioning in Dutch pediatric patients with hereditary spherocytosis

Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease